Glucocorticoid receptor agonist-1 is a potent glucocorticoid receptor agonist with an IC 50 of 2.8 nM extracted from patent WO2017210471A1, compound 41.
性状
Solid
IC50 & Target[1][2]
IC50: 2.8 nM (Glucocorticoid receptor)
体外研究(In Vitro)
Glucocorticoid receptor agonist immunoconjugates are useful for treating autoimmune diseases such as, but not limited to, rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohns disease, pediatric Crohns disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, uveitis, Behcets disease, a spondyloarthropathy, or psoriasis. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, protect from light In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
参考文献
[1]. Michael J. Mcpherson, et al. Glucocorticoid receptor agonist and immunoconjugates thereof. WO2017210471A1.